Advertisement

Clinical Orthopaedics and Related Research®

, Volume 470, Issue 6, pp 1718–1727 | Cite as

Does Ramosetron Reduce Postoperative Emesis and Pain after TKA?

  • In Jun Koh
  • Chong Bum Chang
  • Young-Tae Jeon
  • Jung-Hee Ryu
  • Tae Kyun Kim
Clinical Research

Abstract

Background

Current pain management protocols involving many anesthetic and analgesic drugs reportedly provide adequate analgesia after TKA. However, control of emetic events associated with the drugs used in current multimodal pain management remains challenging.

Questions/purposes

We determined (1) whether ramosetron prophylaxis reduces postoperative emetic events; and (2) whether it influences pain levels and opioid consumption in patients managed with a current multimodal pain management protocol after TKA.

Methods

We randomized 119 patients undergoing TKA to receive either ramosetron (experimental group, n = 60) or no prophylaxis (control group, n = 59). All patients received regional anesthesia, preemptive analgesic medication, continuous femoral nerve block, periarticular injection, and fentanyl-based intravenous patient-controlled analgesia. We recorded the incidence of emetic events, rescue antiemetic requirements, complete response, pain level, and opioid consumption during three periods (0–6, 6–24, and 24–48 hours postoperatively). The severity of nausea was evaluated using a 0 to 10 VAS.

Results

The ramosetron group tended to have a lower incidence of nausea with a higher complete response and tended to have less severe nausea and fewer rescue antiemetic requirements during the 6- to 24-hour period. However, the overall incidences of emetic events, rescue antiemetic requirements, and complete response were similar in both groups. We found no differences in pain level or opioid consumption between the two groups.

Conclusions

Ramosetron reduced postoperative emetic events only during the 6- to 24-hour postoperative period and did not affect pain relief. More efficient measures to reduce emetic events after TKA should be explored.

Level of Evidence

Level I, therapeutic study. See the Guidelines for Authors for a complete description of levels of evidence.

Keywords

Ondansetron Aprepitant Opioid Consumption Femoral Nerve Block Antiemetic Effect 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgment

We thank Bong Young Kong MD, of Seoul National University Bundang Hospital for data collection and patient interviews.

References

  1. 1.
    Apfel CC, Korttila K, Abdalla M, Kerger H, Turan A, Vedder I, Zernak C, Danner K, Jokela R, Pocock SJ, Trenkler S, Kredel M, Biedler A, Sessler DI, Roewer N. A factorial trial of six interventions for the prevention of postoperative nausea and vomiting. N Engl J Med. 2004;350:2441–2451.PubMedCrossRefGoogle Scholar
  2. 2.
    Apfel CC, Laara E, Koivuranta M, Greim CA, Roewer N. A simplified risk score for predicting postoperative nausea and vomiting: conclusions from cross-validations between two centers. Anesthesiology. 1999;91:693–700.PubMedCrossRefGoogle Scholar
  3. 3.
    Apfel CC, Roewer N, Korttila K. How to study postoperative nausea and vomiting. Acta Anaesthesiol Scand. 2002;46:921–928.PubMedCrossRefGoogle Scholar
  4. 4.
    Boogaerts JG, Vanacker E, Seidel L, Albert A, Bardiau FM. Assessment of postoperative nausea using a visual analogue scale. Acta Anaesthesiol Scand. 2000;44:470–474.PubMedCrossRefGoogle Scholar
  5. 5.
    Chen JJ, Frame DG, White TJ. Efficacy of ondansetron and prochlorperazine for the prevention of postoperative nausea and vomiting after total hip replacement or total knee replacement procedures: a randomized, double-blind, comparative trial. Arch Intern Med. 1998;158:2124–2128.PubMedCrossRefGoogle Scholar
  6. 6.
    Choi YS, Shim JK, Yoon do H, Jeon DH, Lee JY, Kwak YL. Effect of ramosetron on patient-controlled analgesia related nausea and vomiting after spine surgery in highly susceptible patients: comparison with ondansetron. Spine (Phila Pa 1976). 2008;33:E602–606.CrossRefGoogle Scholar
  7. 7.
    Dilorio TM, Sharkey PF, Hewitt AM, Parvizi J. Antiemesis after total joint arthroplasty: does a single preoperative dose of aprepitant reduce nausea and vomiting? Clin Orthop Relat Res. 2010;468:2405–2409.CrossRefGoogle Scholar
  8. 8.
    Dorr LD, Chao L. The emotional state of the patient after total hip and knee arthroplasty. Clin Orthop Relat Res. 2007;463:7–12.PubMedGoogle Scholar
  9. 9.
    Fujii Y. Clinical strategies for preventing postoperative nausea and vomitting after middle ear surgery in adult patients. Curr Drug Saf. 2008;3:230–239.PubMedCrossRefGoogle Scholar
  10. 10.
    Fujii Y, Saitoh Y, Tanaka H, Toyooka H. Comparison of ramosetron and granisetron for preventing postoperative nausea and vomiting after gynecologic surgery. Anesth Analg. 1999;89:476–479.PubMedGoogle Scholar
  11. 11.
    Fujii Y, Saitoh Y, Tanaka H, Toyooka H. Ramosetron for preventing postoperative nausea and vomiting in women undergoing gynecological surgery. Anesth Analg. 2000;90:472–475.PubMedGoogle Scholar
  12. 12.
    Fujii Y, Tanaka H. Prevention of nausea and vomiting with ramosetron after total hip replacement. Clin Drug Investig. 2003;23:405–409.PubMedCrossRefGoogle Scholar
  13. 13.
    Fujii Y, Tanaka H, Kawasaki T. Benefits and risks of granisetron versus ramosetron for nausea and vomiting after breast surgery: a randomized, double-blinded, placebo-controlled trial. Am J Ther. 2004;11:278–282.PubMedCrossRefGoogle Scholar
  14. 14.
    Fujii Y, Toyooka H, Tanaka H. Prevention of postoperative nausea and vomiting in female patients during menstruation: comparison of droperidol, metoclopramide and granisetron. Br J Anaesth. 1998;80:248–249.PubMedCrossRefGoogle Scholar
  15. 15.
    Gan TJ. Risk factors for postoperative nausea and vomiting. Anesth Analg. 2006;102:1884–1898.PubMedCrossRefGoogle Scholar
  16. 16.
    Gan TJ, Alexander R, Fennelly M, Rubin AP. Comparison of different methods of administering droperidol in patient-controlled analgesia in the prevention of postoperative nausea and vomiting. Anesth Analg. 1995;80:81–85.PubMedGoogle Scholar
  17. 17.
    Gan TJ, Meyer T, Apfel CC, Chung F, Davis PJ, Eubanks S, Kovac A, Philip BK, Sessler DI, Temo J, Tramer MR, Watcha M. Consensus guidelines for managing postoperative nausea and vomiting. Anesth Analg. 2003;97:62–71.PubMedCrossRefGoogle Scholar
  18. 18.
    Golembiewski J, Tokumaru S. Pharmacological prophylaxis and management of adult postoperative/postdischarge nausea and vomiting. J Perianesth Nurs. 2006;21:385–397.PubMedCrossRefGoogle Scholar
  19. 19.
    Graczyk SG, McKenzie R, Kallar S, Hickok CB, Melson T, Morrill B, Hahne WF, Brown RA. Intravenous dolasetron for the prevention of postoperative nausea and vomiting after outpatient laparoscopic gynecologic surgery. Anesth Analg. 1997;84:325–330.PubMedGoogle Scholar
  20. 20.
    Hahm TS, Ko JS, Choi SJ, Gwak MS. Comparison of the prophylactic anti-emetic efficacy of ramosetron and ondansetron in patients at high-risk for postoperative nausea and vomiting after total knee replacement. Anaesthesia. 2010;65:500–504.PubMedCrossRefGoogle Scholar
  21. 21.
    Hartrick CT, Tang YS, Hunstad D, Pappas J, Muir K, Pestano C, Silvasi D. Aprepitant vs. multimodal prophylaxis in the prevention of nausea and vomiting following extended-release epidural morphine. Pain Pract. 2010;10:245–248.PubMedCrossRefGoogle Scholar
  22. 22.
    Jellish WS, Leonetti JP, Sawicki K, Anderson D, Origitano TC. Morphine/ondansetron PCA for postoperative pain, nausea, and vomiting after skull base surgery. Otolaryngol Head Neck Surg. 2006;135:175–181.PubMedCrossRefGoogle Scholar
  23. 23.
    Kauste A, Tuominen M, Heikkinen H, Gordin A, Korttila K. Droperidol, alizapride and metoclopramide in the prevention and treatment of post-operative emetic sequelae. Eur J Anaesthesiol. 1986;3:1–9.PubMedGoogle Scholar
  24. 24.
    Kazemi-Kjellberg F, Henzi I, Tramer MR. Treatment of established postoperative nausea and vomiting: a quantitative systematic review. BMC Anesthesiol. 2001;1:2.PubMedCrossRefGoogle Scholar
  25. 25.
    Kim MK, Nam SB, Cho MJ, Shin YS. Epidural naloxone reduces postoperative nausea and vomiting in patients receiving epidural sufentanil for postoperative analgesia. Br J Anaesth. 2007;99:270–275.PubMedCrossRefGoogle Scholar
  26. 26.
    Koh IJ, Kang YG, Chang CB, Kwon SK, Seo ES, Seong SC, Kim TK. Additional pain relieving effect of intraoperative periarticular injections after simultaneous bilateral TKA: a randomized, controlled study. Knee Surg Sports Traumatol Arthrosc. 2010;18:916–922.PubMedCrossRefGoogle Scholar
  27. 27.
    Koivuranta M, Laara E, Snare L, Alahuhta S. A survey of postoperative nausea and vomiting. Anaesthesia. 1997;52:443–449.PubMedCrossRefGoogle Scholar
  28. 28.
    Korttila K. The study of postoperative nausea and vomiting. Br J Anaesth. 1992;69(7 suppl 1):20S–23S.Google Scholar
  29. 29.
    Kovac AL. Prevention and treatment of postoperative nausea and vomiting. Drugs. 2000;59:213–243.PubMedCrossRefGoogle Scholar
  30. 30.
    Lee D, Kim JY, Shin JW, Ku CH, Park YS, Kwak HJ. The effect of oral and IV ramosetron on postoperative nausea and vomiting in patients undergoing gynecological laparoscopy with total intravenous anesthesia. J Anesth. 2009;23:46–50.PubMedCrossRefGoogle Scholar
  31. 31.
    Macario A, Weinger M, Carney S, Kim A. Which clinical anesthesia outcomes are important to avoid? The perspective of patients. Anesth Analg. 1999;89:652–658.PubMedGoogle Scholar
  32. 32.
    Maheshwari AV, Blum YC, Shekhar L, Ranawat AS, Ranawat CS. Multimodal pain management after total hip and knee arthroplasty at the Ranawat Orthopaedic Center. Clin Orthop Relat Res. 2009;467:1418–1423.PubMedCrossRefGoogle Scholar
  33. 33.
    Murphy MJ, Hooper VD, Sullivan E, Clifford T, Apfel CC. Identification of risk factors for postoperative nausea and vomiting in the perianesthesia adult patient. J Perianesth Nurs. 2006;21:377–384.PubMedCrossRefGoogle Scholar
  34. 34.
    Myles PS, Williams DL, Hendrata M, Anderson H, Weeks AM. Patient satisfaction after anaesthesia and surgery: results of a prospective survey of 10,811 patients. Br J Anaesth. 2000;84:6–10.PubMedCrossRefGoogle Scholar
  35. 35.
    Parvataneni HK, Shah VP, Howard H, Cole N, Ranawat AS, Ranawat CS. Controlling pain after total hip and knee arthroplasty using a multimodal protocol with local periarticular injections: a prospective randomized study. J Arthroplasty. 2007;22:33–38.PubMedCrossRefGoogle Scholar
  36. 36.
    Parvizi J, Porat M, Gandhi K, Viscusi ER, Rothman RH. Postoperative pain management techniques in hip and knee arthroplasty. Instr Course Lect. 2009;58:769–779.PubMedGoogle Scholar
  37. 37.
    Peters CL, Shirley B, Erickson J. The effect of a new multimodal perioperative anesthetic regimen on postoperative pain, side effects, rehabilitation, and length of hospital stay after total joint arthroplasty. J Arthroplasty. 2006;21:132–138.PubMedCrossRefGoogle Scholar
  38. 38.
    Singelyn FJ, Deyaert M, Joris D, Pendeville E, Gouverneur JM. Effects of intravenous patient-controlled analgesia with morphine, continuous epidural analgesia, and continuous three-in-one block on postoperative pain and knee rehabilitation after unilateral total knee arthroplasty. Anesth Analg. 1998;87:88–92.PubMedGoogle Scholar
  39. 39.
    Tramer MR, Reynolds DJ, Moore RA, McQuay HJ. Efficacy, dose-response, and safety of ondansetron in prevention of postoperative nausea and vomiting: a quantitative systematic review of randomized placebo-controlled trials. Anesthesiology. 1997;87:1277–1289.PubMedCrossRefGoogle Scholar
  40. 40.
    Watcha MF, White PF. Postoperative nausea and vomiting: its etiology, treatment, and prevention. Anesthesiology. 1992;77:162–184.PubMedCrossRefGoogle Scholar
  41. 41.
    Wilson AJ, Diemunsch P, Lindeque BG, Scheinin H, Helbo-Hansen HS, Kroeks MV, Kong KL. Single-dose i.v. granisetron in the prevention of postoperative nausea and vomiting. Br J Anaesth. 1996;76:515–518.PubMedCrossRefGoogle Scholar

Copyright information

© The Association of Bone and Joint Surgeons® 2011

Authors and Affiliations

  • In Jun Koh
    • 1
  • Chong Bum Chang
    • 2
    • 3
  • Young-Tae Jeon
    • 4
  • Jung-Hee Ryu
    • 4
  • Tae Kyun Kim
    • 2
    • 3
  1. 1.Department of Orthopaedic SurgeryUijeongbu St. Mary’s HospitalGyunggidoKorea
  2. 2.Joint Reconstruction CenterSeoul National University Bundang HospitalGyunggidoKorea
  3. 3.Department of Orthopaedic SurgerySeoul National University College of MedicineSeoulKorea
  4. 4.Department of Anesthesiology and Pain MedicineSeoul National University Bundang HospitalSeongamKorea

Personalised recommendations